CAS: 6628-00-8; N-Allylcyclohexanamine

相似化合物

5459-93-8 755715-40-3 18292-76-7

上下游产品

CAS号108-94-1 环己酮 | CAS号107-11-9 丙烯胺 | CAS号108-91-8 环己胺 | CAS号107-18-6 烯丙醇 | CAS号591-87-7 乙酸烯丙酯 | CAS号19573-22-9 Cyclohexane, azido | CAS号106-95-6 烯丙基溴 | CAS号538-75-0 N,N'-二环己基碳酰亚胺 | CAS号6115-03-3 N-prop-2-enylcy... | CAS号5577-68-4 cyclohexylamino... | CAS号108-91-8 环己胺 | CAS号6837-24-7 N-环己基吡咯烷酮 | CAS号3592-81-2 N-环己基-n-丙胺 | CAS号7107-58-6 benzyl N-cycloh... | CAS号5498-74-8 1-氮杂螺环[4.5]癸-2-酮 | CAS号50971-47-6 N-cyclohexyl-N-... | CAS号64330-45-6 1-cyclohexyl-2H...

📜N,N''-二环己基-O-甲基异脲 以 甲苯 作为反应溶剂,化学反应 39.0H,反应生成 烯丙基环己胺
参考文献:在碳二亚胺促进的温和条件下,由脂肪醇和二氧化碳形成有机碳酸盐的机理.dft计算与实验研究
标题:在碳二亚胺促进的温和条件下,由脂肪醇和二氧化碳形成有机碳酸盐的机理.dft计算与实验研究
摘要:二环己基(cyn ç Ncy,Dcc)促进在温度低至310 K和co的中等压力容易形成从脂族醇与二氧化碳有机碳酸酯2(0.1兆帕)以可接受的速率.dcc的转化率是定量的,在330 K下,该反应对碳酸盐的选择性很高.升高温度可提高转化率,但会降低选择性.一项详细的研究使我们能够分离或鉴定在有或没有二氧化碳的情况下,醇与dcc反应形成的中间体.第一步是将醇添加到异丙苯中(已知反应)并形成o-烷基异脲[rhnc(or')nr],其可以通过h键与第二个醇分子相互作用(到目前为止尚未描述过该反应).这样的加合物可以通过NMR检测.在醇中,不存在co 2时,会转化为氨基甲酸酯和仲胺,而在存在co 2时,碳酸二烷基酯(ro)2 Co与尿素[cyhn-Co-Nhcy]一起形成.已经用各种脂族醇如甲醇,乙醇和烯丙醇测试了该反应.尤其是,这是合成碳酸二烯丙酯的便利途径.o-甲基-N,N'-二环己基异脲也可在co
DOI:10.1021/jo050392Y

专利信息

专利号:US-6448425-B1
优先权日:2002-02-19
标题:Preparation of N-substituted aminoorganosilanes
发明人：GEDON STEVEN C; HALE MELINDA
权利人:CROMPTON CORP
摘要:A process is disclosed for the synthesis of N-cycloalkylaminoalkylsilanes, wherein the process comprises hydrogenating the corresponding N-arylaminoalkylsilanes in the presence of a catalytically effective amount of a supported or unsupported catalyst selected from the group consisting of palladium, platinum, nickel, rhenium, rhodium, ruthenium, copper chromite, and mixtures of the foregoing.

专利号:US-3862978-A
优先权日:1967-08-24
标 题:Catalytic synthesis of organic halogen compounds from an ethylenically unsaturated compound and a halogenated organic compound
发明人：DECKER DALTON L; MOORE CARL; TOUSIGNANT WILLIAM F
权利人:DOW CHEMICAL CO
摘要:Method for forming a chemical adduct of an ethylenically unsaturated compound with a halogenated organic compound having on a single carbon atom thereof at least two halogen atoms at least one of which is chlorine, bromine or iodine, characterized by employing a catalyst of which the essential members are copper and an amine selected from piperidine, substituted piperidines, cyclohexylamines and secondary amines on which the hydrocarbyl substituents are allyl, benzyl or lower alkyl radicals.

专利号:US-6384216-B1
优先权日:2000-08-09
标 题 :Purification of alkenyl compounds
发明人：LORENZ RUDOLF ERICH; BOETTCHER ARND; PINKOS ROLF
权利人:BASF AG
摘要:A process for purifying alkenyl compounds having a divalent or trivalent heteroatom in the alpha-position relative to the double bond by distillation comprises carrying out at least two distillations in which the purified alkenyl compounds are obtained from the gas phase by condensation, where the time between the first distillation after the synthesis of the alkenyl compounds and at least one further distillation is at least one day and the purified alkenyl compounds have an APHA color number of <30.

专利号:US-4256903-A
优先权日:1980-03-17
标 题 :Polymer inhibition
发明人：MACDONELL GARY D
权利人:PHILLIPS PETROLEUM CO
摘要:The formation of polysulfone polymer during the synthesis of sulfolenes from conjugated dienes and sulfur dioxide is reduced by the incorporation of a small, effective amount of a mono- and/or dialkenyl amine.

专利号:US-3454657-A
优先权日:1967-08-24
标 题:Catalytic synthesis of organic halogen compounds
发明人：DECKER DALTON L; MOORE CARL; TOUSIGNANT WILLIAM F
权利人:DOW CHEMICAL CO

专利号:US-4329349-A
优先权日:1979-07-25
标 题:6-C1-4 Alkyl-7-phenyl or substituted phenyl-1,6-naphthyridine-5(6H)-ones
发明人：DAMON II ROBERT E; NADELSON JEFFREY
权利人:SANDOZ AG
摘要:Compounds of the formula ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein n R 1 is C 1-4 alkyl, n R 2 is hydrogen, C 1-4 alkyl, C 1-4 alkoxy, halo, trifluoromethyl, C 1-4 alkylthio or --NR 5 R 6 , wherein each of R 5 and R 6 is independently hydrogen or C 1-3 alkyl, n R 3 is hydrogen, C 1-3 alkyl, C 1-3 alkoxy, halo or trifluoromethyl, and n R 4 is hydrogen, C 1-3 alkyl, C 1-3 alkoxy or halo, n their use as muscle relaxants and as anti-inflammatory agents, pharmaceutical compositions comprising them, processes for their synthesis and compounds of the formulae ##STR2## wherein R 1 , R 2 , R 3 and R 4 are as defined above, useful as intermediates in their synthesis.